Brought to you by 
Alliance and Neopharm sell Barrier's dermatology therapies
15 Aug 2011
Executive Summary
Alliance Pharmaceuticals Ltd. (subsidiary of the former Peerless Technology Group, now Alliance Pharma PLC; develops and markets a wide range of niche therapeutics) and Israeli company Neopharm Ltd. (markets branded pharmaceuticals) have licensed sales, marketing, and distribution rights to dermatology drug company Barrier Therapeutics' dermatological products.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alliance and Neopharm sell Barrier's dermatology therapies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice